https://www.selleckchem.com/pr....oducts/ap-3-a4-enobl
After adjustment for confounding factors, reversion from pre-diabetes mellitus to normoglycemia was associated with decreased risks of CVD (HR, 0.78; 95% CI, 0.64-0.96), myocardial infarction (HR, 0.62; 95% CI, 0.40-0.97), stroke (HR, 0.79; 95% CI, 0.63-0.98), and all-cause mortality (HR, 0.82; 95% CI, 0.68-0.99) compared with progression to diabetes mellitus. Conclusions Reversion from fasting plasma glucose-defined pre-diabetes mellitus to normoglycemia was associated with a reduction in the future risk of CVD and all-cause m
Like
Comment
Share
